Effect of topical Tranexamic Acid on management of gastrointestinal bleeding
Phase 2
- Conditions
- pper Gastrointestinal Bleeding.Acute haemorrhagic gastritis
- Registration Number
- IRCT201201148721N1
- Lead Sponsor
- Private Resiurces (Attending and Resident of incharge)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Inclusion Criteria: Symptoms or signs of GI bleeding.
Exclusion Criteria
Pregnancy; Lactation; Gastrointestinal Malignancy; Coagulopathy; History of Thromboembolism; History of myocardial infarction or ischemic cerebrovascular accident; End Stage Renal Disease; Allergy to TA; Undergoing anticoagulation therapy; Congenital or acquired coagulopathy; who were reluctant to enroll in this study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Packed RBC. Timepoint: from intervention to discharge. Method of measurement: patient hospital document.
- Secondary Outcome Measures
Name Time Method 30-day Mortality. Timepoint: From intervantion to 1 month later. Method of measurement: Patients' Hospital Document and Phone Contact.;Tranexamic Acid Complication. Timepoint: during the study. Method of measurement: According to clinical manifestation, physical examination and doppler sonography.;Re-bleeding. Timepoint: From intervention to Discharge. Method of measurement: Patients' Hospital Document.